These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22336167)

  • 1. [Recent advances in molecular pathology of bladder cancer].
    Cheng L; Xu JW; Teng XD; Zhao J
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):779-82. PubMed ID: 22336167
    [No Abstract]   [Full Text] [Related]  

  • 2. Ki67, p53, nm23, and DNA cytometry in bladder cancer: potential markers for detection of recurrence?
    Feil G; Krause FS; Zumbraegel A; Wechsel HW; Bichler KH
    Adv Exp Med Biol; 2003; 539(Pt A):99-109. PubMed ID: 15088899
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical applications of molecular biomarkers in urothelial carcinoma of bladder].
    Cheng L; Xu JW; He JJ; Zhao J; Teng XD
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):714-7. PubMed ID: 22321559
    [No Abstract]   [Full Text] [Related]  

  • 4. Reassessment of p53 immunohistochemistry thresholds in invasive high grade bladder cancer shows a better correlation with TP53 and FGFR3 mutations.
    Hodgson A; van Rhijn BWG; Kim SS; Ding C; Saleeb R; Vesprini D; Liu SK; Yousef GM; van der Kwast TH; Xu B; Downes MR
    Pathol Res Pract; 2020 Nov; 216(11):153186. PubMed ID: 32861170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIU-ICUD consultation on bladder cancer: basic science.
    McConkey DJ; Lerner SP
    World J Urol; 2019 Jan; 37(1):15-29. PubMed ID: 30547196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder.
    Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
    Urol Oncol; 2007; 25(6):468-75. PubMed ID: 18047954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasion of the bladder by transitional cell carcinoma: its relation to histologic grade and expression of p53, MIB-1, c-erb B-2, epidermal growth factor receptor, and bcl-2.
    Vollmer RT; Humphrey PA; Swanson PE; Wick MR; Hudson ML
    Cancer; 1998 Feb; 82(4):715-23. PubMed ID: 9477105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome.
    van Rhijn BW; Vis AN; van der Kwast TH; Kirkels WJ; Radvanyi F; Ooms EC; Chopin DK; Boevé ER; Jöbsis AC; Zwarthoff EC
    J Clin Oncol; 2003 May; 21(10):1912-21. PubMed ID: 12743143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma.
    Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
    J Urol; 2007 Feb; 177(2):481-7; discussion 487. PubMed ID: 17222615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 protein expression and proliferative activity in imprints of superficial transitional cell carcinoma of the bladder.
    Ioakim-Liossi A; Pantazopoulos D; Karakitsos P; Athanassiadou P; Aroni K; Giahnaki AE; Athanassiades P
    Anal Quant Cytol Histol; 2000 Jun; 22(3):223-8. PubMed ID: 10872039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
    Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y
    J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P27(Kip1) and Ki-67 expression analysis in transitional cell carcinoma of the bladder.
    Dybowski B; Kupryjańczyk J; Rembiszewska A; Pykało R; Borkowski A
    Urol Res; 2003 Dec; 31(6):397-401. PubMed ID: 14517702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further testing of morphometric grading in T(A,1) urothelial carcinomas of the urinary bladder and the additional value of p53 immunoquantitation.
    Bol MG; Baak JP; Janssen EA; Breeuwsma NG; de Bruin PC
    Anal Quant Cytol Histol; 2002 Apr; 24(2):114-20. PubMed ID: 12026049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is protein p53 an independent prognostic factor in bladder carcinoma?].
    Keilholz L
    Strahlenther Onkol; 1995 Sep; 171(9):543-4. PubMed ID: 7570304
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial comment on: Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study.
    Montironi R; Lopez-Beltran A; Cheng L
    Eur Urol; 2008 Oct; 54(4):843-4. PubMed ID: 18166261
    [No Abstract]   [Full Text] [Related]  

  • 16. p53 but not erbB-2 expression is associated with rapid tumor proliferation in urinary bladder cancer.
    Moch H; Sauter G; Mihatsch MJ; Gudat F; Epper R; Waldman FM
    Hum Pathol; 1994 Dec; 25(12):1346-51. PubMed ID: 8001930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8q24 amplification in transitional cell carcinoma of bladder.
    Visapää H; Seligson D; Eeva M; Gaber F; Rao J; Belldegrun A; Palotie A
    Appl Immunohistochem Mol Morphol; 2003 Mar; 11(1):33-6. PubMed ID: 12610354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours.
    van Oers JM; Wild PJ; Burger M; Denzinger S; Stoehr R; Rosskopf E; Hofstaedter F; Steyerberg EW; Klinkhammer-Schalke M; Zwarthoff EC; van der Kwast TH; Hartmann A
    Eur Urol; 2007 Sep; 52(3):760-8. PubMed ID: 17240035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and Prognostic Implications of FGFR3
    Geelvink M; Babmorad A; Maurer A; Stöhr R; Grimm T; Bach C; Knuechel R; Rose M; Gaisa NT
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30154342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reply to the letter: "In reference to the article: Multivariate analysis of recurrence and progression of stage T1 transitional cell carcinoma of the bladder. Prognostic value of p53 and kI67].
    Rodríguez Alonso A; Pita Fernández S
    Actas Urol Esp; 2003 Oct; 27(9):746-7. PubMed ID: 14626689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.